Rep. Darin LaHood

Maddy summaryThis bill changes a tax rule for Real Estate Investment Trusts (REITs) that use taxable subsidiaries. It increases the percentage limit for assets held in these subsidiaries from 20% to 25% of a REIT's total assets, directly affecting REIT companies that operate through such subsidiaries. The key provision amends the Internal Revenue Code to restore this higher asset threshold, which had been reduced earlier. The change applies to taxable years starting after December 31, 2025.

Maddy summaryThe Medical Supply Chain Resiliency Act (HR 2213) establishes a framework for the U.S. to form agreements with foreign countries that commit to reliable medical supply chains during emergencies. It allows the President to negotiate "trusted trade partner agreements" that reduce trade barriers (like duties and quotas) for medical goods with countries meeting specific criteria, such as maintaining open trade during health crises and protecting intellectual property. These agreements require Congressional review and approval, with ongoing monitoring to ensure partners uphold commitments. The bill directly affects U.S. trade policy, foreign governments seeking partnerships, and the medical supply industry by aiming to diversify sources and secure critical products like pharmaceuticals and medical devices.

Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.  Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care  means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later. Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions. The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.

Maddy summaryHR 1156, the Pandemic Unemployment Fraud Enforcement Act, extends the time limit for prosecuting fraud related to pandemic unemployment programs. It adds a 10-year window for criminal or civil actions against individuals who falsely claimed benefits under Pandemic Unemployment Assistance (PUA), Federal Pandemic Unemployment Compensation (FPUC), or Mixed Earner Unemployment Compensation (MEUC). The law applies only to fraud committed during these specific pandemic-era programs and does not revive cases where the original statute of limitations had already expired before this bill passed. This change gives authorities more time to pursue fraud cases without altering the programs' core eligibility rules.

Metastatic Breast Cancer Access to Care Act This bill expedites payment of Social Security Disability Insurance (SSDI) benefits and eligibility for Medicare coverage for those with metastatic breast cancer (i.e., breast cancer that has spread to other sites in the body). Specifically, the bill eliminates the 5-month waiting period for SSDI benefits and the subsequent 24-month waiting period for Medicare coverage for individuals with metastatic breast cancer. Under current law, individuals generally must wait 5 months after the onset of disability to begin receiving SSDI benefits and an additional 24 months to become eligible for Medicare.

Maddy summaryThis bill changes how individual investors in mutual funds (regulated investment companies) are taxed on certain dividends. It allows investors to defer paying tax on capital gain dividends that are automatically reinvested in additional fund shares through a dividend reinvestment plan. The deferred tax is recognized later when the investor sells shares or upon their death. It also establishes that shares acquired through this reinvestment are treated as held for over one year from the start, potentially qualifying for long-term capital gains rates. The rule applies only to individual investors (not estates, trusts, or dependents claimed by others).

Maddy summaryThis is a non-binding resolution (HRES 206), not a legislative bill. It expresses the House's support for preserving the "stepped-up basis" tax provision (Section 1014 of the Internal Revenue Code), which allows heirs to reset the tax cost basis of inherited assets like farmland or business equipment to their current market value. The resolution cites that 98% of farms and 19% of businesses are family-owned, noting that eliminating this provision could increase taxes for 66% of midsized farms. It specifically urges opposition to new taxes on family farms and small businesses but does not change any tax law or policy.

Maddy summaryThe Infant Formula Made in America Act of 2025 creates two tax credits to incentivize domestic infant formula production. It offers a 30% investment credit for manufacturers who build or expand facilities to make U.S.-made infant formula (with a total credit cap of $750 million), plus a $2 per pound production credit for formula sold in the U.S. (capped at 18 million pounds annually). The credits are limited to manufacturers with global revenue under $750 million and require at least 50% of formula produced with the investment credit to be sold within the U.S. within one year. The bill includes recapture provisions if manufacturers fail to meet these requirements, and applies to facilities starting construction after the bill's enactment.

Maddy summaryHR 1990, the American Innovation and R&D Competitiveness Act of 2025, amends tax rules for businesses to make research and development (R&D) costs more flexible. It allows companies to deduct R&D expenses immediately as business costs (instead of capitalizing them) or to spread these costs over a minimum 60-month period. The bill clarifies which R&D expenses qualify, excludes land improvements and mineral exploration costs, and ensures companies can claim R&D tax credits without conflict with expense treatment. This directly affects businesses that conduct R&D, changing how they account for these costs on tax returns starting for 2022 taxable years.

Maddy summaryHR 1940, the Tanning Tax Repeal Act of 2025, removes a federal excise tax on indoor tanning services. It directly affects tanning salons and businesses providing these services by eliminating the tax they previously paid. The bill repeals Chapter 49 of the Internal Revenue Code, which imposed the tax, and the change takes effect for services provided after the bill becomes law. This is a straightforward tax repeal with no new requirements or funding mechanisms.